Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.

NCT00204074 is registered in ClinicalTrials.gov with University Hospital, Linkoeping as lead sponsor.

NCT NCT00204074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00204074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.
Lead sponsor
University Hospital, Linkoeping
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 31, 2001
Completion date
July 31, 2005
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine